36th Annual JPM Healthcare Conference

gtmrick
December 25, 2017
Uncategorized

In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

Vasomune Announces FDA Allowance of IND Application for AV-001 for the Treatment of Hospitalized Patients with COVID-19

Preventing the flu: Researchers looking for a new approach

Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment

About

Vasomune Therapeutics 2020 © All Rights Reserved.